However, increased expression of FCRL3, SKAP2, and AP003774 was associated with lower risk of T1D and RA, while decreased expression of BACH2 and RPS26 increased immune disease risk (Fig. 3E). This evidence concerns the gene RPS26 and type 1 diabetes mellitus.